Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 152.63 USD -0.25% Market Closed
Market Cap: 17B USD
Have any thoughts about
Quest Diagnostics Inc?
Write Note

Operating Margin
Quest Diagnostics Inc

13.9%
Current
17%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.9%
=
Operating Profit
1.3B
/
Revenue
9.5B

Operating Margin Across Competitors

Country US
Market Cap 17.1B USD
Operating Margin
14%
Country US
Market Cap 75.6B EUR
Operating Margin
4%
Country US
Market Cap 77.9B USD
Operating Margin
4%
Country US
Market Cap 56B USD
Operating Margin
3%
Country DE
Market Cap 26B EUR
Operating Margin
7%
Country DE
Market Cap 18.8B EUR
Operating Margin
7%
Country US
Market Cap 19.3B USD
Operating Margin
9%
Country US
Market Cap 16.9B USD
Operating Margin
8%
Country DE
Market Cap 13B EUR
Operating Margin
7%
Country US
Market Cap 12.7B USD
Operating Margin
15%
Country AU
Market Cap 13.2B AUD
Operating Margin
9%
No Stocks Found

Quest Diagnostics Inc
Glance View

Market Cap
17.1B USD
Industry
Health Care
Economic Moat
None

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

DGX Intrinsic Value
150.73 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.9%
=
Operating Profit
1.3B
/
Revenue
9.5B
What is the Operating Margin of Quest Diagnostics Inc?

Based on Quest Diagnostics Inc's most recent financial statements, the company has Operating Margin of 13.9%.